NEWSROOM

Medical Devices

Aclarion Welcomes Advocate Health as CLARITY Trial Site

Aclarion Welcomes Advocate Health as CLARITY Trial Site

May 5, 2025

Advocate Health actively participates in research studies and is an innovator in technology, including spine The CLARITY trial is designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain Nociscan aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI) Press Audio: BROOMFIELD, Colo., May 05, 2025 - PRISM MediaWire - Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON,...

Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis

Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis

Apr 21, 2025

Independent Cost-Effectiveness Analysis Concludes Nociscan is Effective and Less Costly Compared to Provocative Discography Conclusions Illustrate Nociscan Saves $1,712 per Patient and Improves Surgical Success by 10% Listen: BROOMFIELD, Colo., April 21, 2025 - PRISM MediaWire - Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians...

American Shared Hospital Services Announces Annual Shareholder Meeting to be Held on Thursday, June 26, 2025

American Shared Hospital Services Announces Annual Shareholder Meeting to be Held on Thursday, June 26, 2025

Apr 11, 2025

Listen: SAN FRANCISCO, CA, April 11, 2025 - PRISM MediaWire - American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services through its leasing or direct patient care services segments, today announced that its Annual Meeting of Shareholders will be held on Thursday, June 26, 2025, at 9:00 a.m. CT. The Annual Meeting will be an in-person meeting. For those who wish to...

Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis

Aclarion to Present at the Planet MicroCap Showcase: VEGAS in Partnership with MicroCapClub

Apr 9, 2025

Wednesday, April 23, 2025 & 1x1 Meetings on Thursday, April 24, 2025 Broomfield, CO, April 9, 2025 - PRISM MediaWire -Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2025 in partnership with...

American Shared Hospital Services Announces Annual Shareholder Meeting to be Held on Thursday, June 26, 2025

American Shared Hospital Services to Present at the Planet MicroCap Showcase: VEGAS in partnership with MicroCapClub

Apr 9, 2025

Wednesday, April 23, 2025 & 1x1 Meetings on Thursday, April 24, 2025 SAN FRANCISCO, April 09, 2025 - American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services through its leasing or direct patient care services segments, today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub on Wednesday, April 23,...

BioStem Technologies to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on April 14, 2025

BioStem Technologies to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on April 14, 2025

Apr 8, 2025

Conference Call and Webcast to be held at 4:30 PM ET POMPANO BEACH, Fla., April 08, 2025 - PRISM MediaWire - BioStem Technologies Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, announces that it will release its fourth quarter and full year 2024 financial results on Monday, April 14, 2025, and host a conference call and webcast at 4:30 PM ET. The webcast will feature an overview...

American Shared Hospital Services Announces Annual Shareholder Meeting to be Held on Thursday, June 26, 2025

American Shared Hospital Services Reports Fourth Quarter and Strong Full Year 2024 Financial Results

Apr 4, 2025

Appoints Gary Delanois as Chief Executive Officer Conference Call Scheduled for 1:00 PM ET Today SAN FRANCISCO, CA, April 4, 2025 - PRISM MediaWire - American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services through its leasing or direct patient care services segments, today announced financial results for the fourth quarter and full year ended December 31, 2024. Key...

Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis

Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California

Apr 2, 2025

MICSC are leaders in Los Angeles providing MRI and Diagnostic Imaging services MICSC expands access to Nociscan beyond Beverly Hills now available in Santa Monica Broomfield, CO, April 2, 2025 - PRISM MediaWire - Aclarion, Inc.,(“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today its Nociscan...

American Shared Hospital Services Announces Annual Shareholder Meeting to be Held on Thursday, June 26, 2025

American Shared Hospital Services Announces Fourth Quarter and Full Year 2024 Earnings Conference Call

Mar 31, 2025

Call Scheduled April 4th at 1:00 PM ET SAN FRANCISCO, March 31, 2025 - PRISM MediaWire - American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of stereotactic radiosurgery and advanced radiation therapy cancer treatment services, today announced that the Company will hold a conference call to discuss its fourth quarter and full year 2024 financial results on April 4th at 1:00 pm ET. The fourth quarter and full-year 2024 financial results press release will...

SS Innovations Continues its International Growth, Receiving Medical Device Regulatory Approvals for the SSi Mantra 3 Surgical Robotic System in both the Philippines and Ukraine

SS Innovations Continues its International Growth, Receiving Medical Device Regulatory Approvals for the SSi Mantra 3 Surgical Robotic System in both the Philippines and Ukraine

Mar 28, 2025

Fort Lauderdale, Fla. March 28, 2025 - PRISM MediaWire - SS Innovations International, Inc. (OTC: SSII) (“SS Innovations” or the “Company”), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable for and accessible to a global population, has received regulatory approvals for its SSi Mantra 3 Surgical Robotic System in both the Philippines and Ukraine. SS Innovations International along with RBGM Medical Express Sales Inc., its Manila...

SS Innovations Continues its International Growth, Receiving Medical Device Regulatory Approvals for the SSi Mantra 3 Surgical Robotic System in both the Philippines and Ukraine

SS Innovations International, Inc. Achieves Another Milestone by Successfully Performing Over 2,000 km North-to-South Robotic Cardiac Telesurgery with its SSi Mantra 3 Surgical Robotic System

Mar 27, 2025

The SSI Mantra 3 Surgical Robotic System enabled a seamless connection from SS Innovations headquarters in Gurugram, India to Aster CMI Hospital in Bengaluru, India covering a distance over 2,000 km. The SSi Mantra, India’s first CDSCO*-approved surgical robotic system for telesurgery, brings precision and accessibility to complex surgical procedures. Fort Lauderdale, FL, March 27, 2025 - PRISM MediaWire - SS Innovations International, Inc. (OTC: SSII) (“SS...

Aclarion Welcomes Advocate Health as CLARITY Trial Site

Aclarion Provides Shareholder Update

Mar 13, 2025

Broomfield, CO, March 13, 2025 - PRISM MediaWire - Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today that it has issued an 8k filing that provides an update for stakeholders to review. The filing can be viewed here: The Company intends on filing its 10K by the end of March and...

SS Innovations Continues its International Growth, Receiving Medical Device Regulatory Approvals for the SSi Mantra 3 Surgical Robotic System in both the Philippines and Ukraine

SS Innovations Unveils India’s First Mobile Tele-Surgical Unit at SMRSC 2025

Mar 13, 2025

Fort Lauderdale, FL, March 13, 2025 - PRISM MediaWire - SS Innovations International, Inc. (OTC: SSII) (“SS Innovations” or the “Company”), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable for and accessible to a global population, announced that it unveiled its Mobile Tele-Surgical Unit, aimed at improving remote surgical access and healthcare delivery at the Company’s Second Global Multi-Specialty Robotic Surgery Conference...

SS Innovations Continues its International Growth, Receiving Medical Device Regulatory Approvals for the SSi Mantra 3 Surgical Robotic System in both the Philippines and Ukraine

SS Innovations International Launches the 2nd Global Robotic Surgery Conference, SMRSC 2025

Mar 7, 2025

Fort Lauderdale, Fla., March 7, 2025 - PRISM MediaWire - SS Innovations International, Inc. (OTC: SSII) (“SS Innovations” or the “Company”), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable for and accessible to a global population, announced the launch of its 2nd Global Multi-Specialty Robotic Surgery Conference (SMRSC 2025), organized in collaboration with leading medical societies from both national and international...

Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis

Aclarion Announces First Commercial Agreement with Scripps Health

Mar 3, 2025

Agreement expands access to Nociscan technology for leading spine physicians and more than 3.2M people in the greater San Diego Metro area Nociscan leverages MR Spectroscopy (MRS) and Augmented Intelligence (AI) to Identify Sources of Chronic Low Back Pain Broomfield, CO, March 3, 2025 - PRISM MediaWire - Aclarion, Inc.,(“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to...

Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis

Aclarion, Inc. Announces Adjournment of Special Meeting of Stockholders

Feb 28, 2025

Meeting adjourned to Wednesday, March 5, 2025 at 9:30 a.m. Mountain Time BROOMFIELD, Colo., Feb. 28, 2025 - PRISM MediaWire - Aclarion, Inc. ("Aclarion" or the "Company") (NASDAQ: ACON) (NASDAQ: ACONW), a healthcare technology company that leverages Magnetic Resonance Spectroscopy ("MRS"), artificial intelligence and a proprietary biomarker to optimize clinical treatments for low back and neck pain, today announced that its Special Meeting of Stockholders (the “Special Meeting”) scheduled for...

BioStem Technologies to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on April 14, 2025

BioStem Receives Institutional Review Board (IRB) Approval to Advance Clinical Trial Demonstrating the Therapeutic Benefits of BioREtain® Technology in Treating Venous Leg Ulcers

Feb 24, 2025

Study comparing BioStem’s proprietary amnion chorion allograft versus the standard of care aims to demonstrate superior outcomes, further validating its clinical efficacy to support market expansion POMPANO BEACH, FL, February 24, 2025 - PRISM MediaWire - BioStem Technologies, Inc. a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, announces Institutional Review Board (IRB) approval for a clinical...

Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis

Aclarion to Showcase Groundbreaking NOCISCAN™ Technology at the 2025 Spine Summit

Feb 20, 2025

Dr. Nicholas Theodore to highlight NOCISCAN capabilities combining MR Spectroscopy and augmented intelligence (AI) NOCISCAN is an innovative decision support tool that helps physicians personalize treatment for chronic low back pain BROOMFIELD, Colo., February 20, 2025 - PRISM MediaWire - Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians...

Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis

Aclarion Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy (MRS) Data Processing to Identify Pain and Infection Biomarkers Throughout the Body

Feb 11, 2025

Recent Notice of Allowance is for Aclarion’s 24th issued US patent Propionic acid (PA) is a biomarker the literature suggests may be indicative of bacterial infection and pain in an intervertebral disc Patent will expand Aclarion’s proprietary rights to use MRS to measure propionic acid as a biomarker for the identification of potential infection and pain throughout the body Broomfield, CO, February 11, 2025 - PRISM MediaWire - Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON,...

SS Innovations International Performs World’s First Robotic Cardiac Telesurgeries with its SSi Mantra 3

SS Innovations International Performs World’s First Robotic Cardiac Telesurgeries with its SSi Mantra 3

Jan 13, 2025

A Robotic-Assisted Internal Mammary Artery Harvesting Telesurgery procedure was successfully completed in 58 minutes. The world’s first Robotic Beating Heart Totally Endoscopic Coronary Artery Bypass (TECAB) Telesurgery was performed with a latency of only 40 milliseconds (less than 1/20th of a second). The procedures were performed using the SSi Mantra 3 Surgical Robotic System which was remotely connected from SS Innovations’ headquarters in Gurugram, India to Manipal Hospital in Jaipur,...

BioStem Technologies Announces Record Preliminary Fourth Quarter Net Revenue of $102.9 Million, with Full-Year 2024 Net Revenue Expected to Reach $301.8 Million

BioStem Technologies Announces Record Preliminary Fourth Quarter Net Revenue of $102.9 Million, with Full-Year 2024 Net Revenue Expected to Reach $301.8 Million

Jan 13, 2025

POMPANO BEACH, Fla., January 13, 2025 - PRISM MediaWire - BioStem Technologies, Inc. (OTC: BSEM) (“BioStem”, “we”, “us”, or “our”), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, today announced selected preliminary financial results for the fiscal fourth quarter and full year ended December 31, 2024. 2024 Preliminary Fourth Quarter and Year End Results: Fourth quarter net revenue is expected to...

SS Innovations Announces Completion of BDO Audit Process and Issues Update on Plans for NASDAQ Uplisting

SS Innovations Announces Completion of BDO Audit Process and Issues Update on Plans for NASDAQ Uplisting

Dec 11, 2024

FORT LAUDERDALE, Fla., Dec. 11, 2024 - PRISM MediaWire - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, today announced that its new independent registered public accounting firm, BDO India LLP (“BDO”), has completed the re-audit of the Company’s consolidated financial statements for the years ended December...

India’s First CDSCO Certified Robotic System for Telesurgery: SSi Mantra Leads the Way

India’s First CDSCO Certified Robotic System for Telesurgery: SSi Mantra Leads the Way

Dec 10, 2024

SS Innovations becomes the first and only company in India to receive regulatory approval for Telesurgery and Teleproctoring capabilities of a surgical robotic system, its SSi Mantra, marking a significant achievement in surgical robotics SS Innovations reinforces India's position as a hub for technological innovation in healthcare using the SSi Mantra - Made in India, for the World The SSi Mantra integrates innovative advancements in robotic surgery, offering surgeons enhanced precision and...

SS Innovations Marks a Milestone with First Robotic Cardiac Surgery in Indonesia

SS Innovations Marks a Milestone with First Robotic Cardiac Surgery in Indonesia

Nov 26, 2024

SS Innovations marks a milestone with the successful completion of Indonesia’s first robotic cardiac surgery using its SSi Mantra Surgical Robotic System. Dr. Sudhir Srivastava, Founder, Chairman, and CEO of SS Innovations successfully performed the first Beating Heart Totally Endoscopic Coronary Artery Bypass (TECAB) in Indonesia, a significant achievement in the field of robotic cardiac surgery. The developed and made-in-India SSi Mantra Surgical Robotic System highlights India’s position as...

American Shared Hospital Services Announces Annual Shareholder Meeting to be Held on Thursday, June 26, 2025

American Shared Hospital Services Reports Third Quarter 2024 Financial Results

Nov 13, 2024

- Revenue increases 36.3% period over period - Conference Call on November 13th at 1:00 pm ET SAN FRANCISCO, CA, November 13, 2024 ‒ American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy cancer treatment systems and services, today announced financial results for the third quarter ended September 30, 2024. Third Quarter 2024 and Recent Highlights Total revenue in...

American Shared Hospital Services Announces Key Management Appointments

American Shared Hospital Services Announces Key Management Appointments

Oct 18, 2024

Hires Gary Delanois, Seasoned Radiation Oncology Services Executive, as Chief Operating Officer Promotes Ranjit Pradhan to Senior Vice President of Sales and Marketing SAN FRANCISCO, CA, October 18, 2024 - PRISM MediaWire - American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy cancer treatment systems and services, today announced the appointment of Gary Delanois as...

PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology

PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology

Sep 13, 2024

NEW YORK, September 13, 2024 - PRISM MediaWire - PRISM MarketView presents an exclusive Q&A with Brent Ness, CEO and Director of Aclarion, Inc. (Nasdaq: ACON). As a disruptive healthcare technology company focused on chronic low back pain, Aclarion is at the forefront of developing noninvasive tools to help physicians identify the source of pain in spinal discs, potentially revolutionizing the standard of care for this widespread and debilitating condition. Aclarion's Nociscan platform,...

SS Innovations Conducts Interactive Meeting with the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) and Updates its Expected FDA Approval Timeline

SS Innovations Conducts Interactive Meeting with the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) and Updates its Expected FDA Approval Timeline

Sep 11, 2024

Fort Lauderdale, FL., September 11, 2024 - PRISM MediaWire - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, today issued an update on its progress and timeline in obtaining U.S. Food and Drug Administration (“FDA”) approvals to market the SSi Mantra Surgical Robotic System (“SSi Mantra”) in the United...

PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology

Aclarion Added to PRISM Emerging Medical Devices Index

Sep 6, 2024

Company's industry-first technology addresses chronic low back pain Aclarion secured its first commercial agreement with Michigan's Sheridan Community Hospital PRISM Emerging Medical Devices Index features companies at forefront of innovation and market disruption in medtech NEW YORK, September 06, 2024 – PRISM MarketView, a leading provider of market insights and company news, is excited to announce that Aclarion, Inc. (NASDAQ: ACON) has been added to the PRISM Emerging Medical Devices Index,...

SS Innovations International, Inc. Announces First Mantra Surgical Robotic System Sale in South America

SS Innovations International, Inc. Announces First Mantra Surgical Robotic System Sale in South America

Sep 3, 2024

SS Innovations receives Regulatory Approval for Clinical Use in Ecuador SS Innovations Partners with Medical Device Firm Ingemedica S.A. for Distribution in Ecuador The first SSi Mantra Surgical Robotic System to be installed at Interhospital, Guayaquil City, Ecuador Fort Lauderdale, FL., September 3, 2024 - SS Innovations International, Inc. (the Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery...